ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Methods Project 4: Clinical Trial

ClinicalTrials.gov ID: NCT01867242

Public ClinicalTrials.gov record NCT01867242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PROJECT 4: CLINICAL TRIAL METHODS FOR ASSESSING A TOBACCO PRODUCT Part of "MODELS FOR TOBACCO PRODUCT EVALUATION

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Cigarette smokers who are eligible will enter a Camel Snus sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and will then be randomized to one of the three experimental conditions for 8 weeks. Tobacco use patterns, subjective responses to product, and nicotine and toxicant exposure will be assessed.

Study identification

NCT ID: NCT01867242
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: University of Minnesota; Other
Enrollment: 150 participants

Conditions and interventions

Conditions

Smoker

Interventions

Cigarettes Other
Snus Other

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2013
Primary completion: Jan 31, 2017
Completion: Apr 30, 2018
Last update posted: May 2, 2023

2013 – 2018

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Masonic Cancer Center, University of Minnesota	Minneapolis	Minnesota	55455	—
Roswell Park Cancer Center	Buffalo	New York	14263	—
Ohio State University Comprehensive Cancer Center	Columbus	Ohio	43210	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01867242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 2, 2023 · Synced Sep 2, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01867242 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →